Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 14/20 | 0.56 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CCNK | O75909 | 1/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | CCND3 | P30281 | 1/20 | 0.36 |
| ▸ | CDK9 | P50750 | 1/20 | 0.36 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2712367 | 0.96 | PIK3CA (0.60) | PIK3CAPIK3CDMAPTMEN1TSHR | |
| SCHEMBL2712876 | 0.89 | PIK3CA (0.59) | PIK3CAPIK3CD | |
| SCHEMBL2712287 | 0.88 | PIK3CA (0.44) | PIK3CAPIK3CD | |
| SCHEMBL2711742 | 0.87 | PIK3CA (0.51) | PIK3CAPIK3CD | |
| SCHEMBL2711063 | 0.87 | PIK3CA (0.53) | PIK3CAPIK3CDMAPTMEN1KMT2A | |
| SCHEMBL2712028 | 0.86 | PIK3CA (0.52) | PIK3CAPIK3CD | |
| SCHEMBL3784742 | 0.86 | PIK3CA (0.50) | PIK3CAPIK3CD | |
| SCHEMBL3784969 | 0.86 | PIK3CA (0.50) | PIK3CAPIK3CD | |
| SCHEMBL3784744 | 0.86 | PIK3CA (0.50) | PIK3CAPIK3CD | |
| SCHEMBL2727603 | 0.86 | PIK3CA (0.42) | PIK3CAPIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445886-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USES | Amgen, Inc (US) | 2012-05-02 | — | — | EP | disclosed |
| WO-2010151791-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USES | AMGEN INC. (US) | 2010-12-29 | — | — | WO | disclosed |